Jubilant Pharmova Ltd

NSE: JUBLPHARMA · BSE: 530019 · Pharmaceuticals & Biotechnology · 29 announcements

Share price: ₹974.60
Market cap: ₹15,524 Cr
Revenue (annual): ₹8,280 Cr
Net profit (annual): ₹398.5 Cr
P/E (TTM): 44.1×Sector 47.3×
Promoter holding: 47.68%+0.00% QoQ
FII holding: 15.87%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Legal & Regulatory 2 Annual General Meeting 2 Results Update 1 Production Started 1 Financial Results 1 Business Update 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

1 Sep 2026 12:42 IST BSE

Legal & Regulatory

Jubilant Pharmova Legal & Regulatory

Jubilant Pharmova Limited received a GST show cause notice proposing a demand of ₹87.31 Crore. The demand includes tax, interest, and penalties for FY 2022-2023.

Value: ₹87.31 Cr

Read the filing ↗

28 Aug 2026 10:08 IST BSE

Legal & Regulatory

Jubilant Pharmova Legal & Regulatory

Jubilant Pharmova's subsidiary received a GST show-cause notice for Rs. 105.50 Crore. The company is contesting the demand involving GST and an equal penalty.

Value: ₹105.5 Cr

Read the filing ↗